Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor [Phase 2]
Phase 2 trial evaluating an anti-PD-1 antibody in a multimodal combination as first-line treatment for advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors [Phase 2]
Phase 2 study of the PD-L1 Probody therapeutic CX-072 in combination with other anticancer therapy in adults with solid tumors, including un…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours [Phase 1]
Phase 1 dose-escalation and expansion study of IPN60090 in patients with advanced solid tumors; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 study of YL-15293 in advanced solid tumors with KRAS G12C mutation is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) [Phase 2]
Phase 2 clinical trial evaluating ADC with hypofractionated radiotherapy followed by sequential PD-1/PD-L1 blockade with GM-CSF and IL-2 for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients [Phase 2]
Phase 2 clinical trial investigating local radiotherapy in combination with immunotherapy for advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating galunisertib in combination with nivolumab for advanced solid tumors, including recurrent or refractory non-small…
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3415244 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of LY3415244 in advanced solid tumors was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies [Phase 1, Phase 2]
Clinical trial update for CN202 in adults with locally advanced or metastatic solid tumors or hematologic malignancies (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors [Phase 1]
Phase 1 study of ramucirumab in pediatric patients with refractory solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients [Phase 2]
Phase 2 safety study of Oraxol (HM30181 + oral paclitaxel) in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]
A two-phase clinical trial evaluating AK-01 (LY3295668) in solid tumors has completed phases 1 and 2 with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: ATG-008 Combined With Toripalimab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial updates for ATG-008 in combination with toripalimab in advanced solid tumors are in Phase 1 and Phase 2, with status not disc…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Open-label Phase I/II study investigating manganese plus radiotherapy in patients with metastatic solid tumors or lymphoma; current status a…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer [Phase 1]
Phase 1 safety study of selinexor (KPT-330) in advanced or metastatic solid tumors has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients [Phase 1]
Phase 1/open-label pharmacokinetic study assessing interactions between tazemetostat and CYP enzymes and gastric pH in patients with B-cell …
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases [Phase 2]
Phase 2 trial evaluating apatinib combined with SHR-1210 as second-line therapy in solid tumors with liver metastases.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors. [NA]
Clinical trial comparing three tissue acquiring techniques during EUS-guided biopsies of solid tumors has been terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) [Phase 1]
Phase 1 study evaluating pembrolizumab monotherapy and combination therapy in advanced solid tumors and lung cancer; completed with results …
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors [Phase 2]
Phase 2 trial update for HX008, a recombinant human anti-PD-1 monoclonal antibody, in advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating Magrolimab (Hu5F9-G4) with cetuximab in solid tumors and advanced colorectal cancer completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation [Phase 1, Phase 2]
Clinical trial update for enasidenib (AG-221) in adults with advanced solid tumors, glioma, or angioimmunoblastic T-cell lymphoma harboring …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial of ridaforolimus and vorinostat in advanced solid tumors or lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym022 (anti-LAG-3) in patients with advanced solid tumors or lymphomas has finished enrollment with results posted…